View in EDS

Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: an Evaluation of the COVID-19 Pandemic.

Saved in:
Bibliographic Details
Title: Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: an Evaluation of the COVID-19 Pandemic.
Authors: Del Vecchio NJ; Fred Hutchinson Cancer Center Seattlie, Washington United States., Doria-Rose VP; National Cancer Institute Bethesda, MD United States., Todd KW; Fred Hutchinson Cancer Center Seattle, WA United States., Rendle KA; University of Pennsylvania Philadelphia United States., Chubak J; Kaiser Permanente Washington Health Research Institute Seattle, WA United States., Halm EA; Rutgers Health New Brunswick, New Jersey United States., Alonge OD; Marshfield Clinic Marshfield, Wisconsin United States., Issaka RB; Fred Hutchinson Cancer Center Seattle, WA United States., Neslund-Dudas C; Henry Ford Health System Detroit, Michigan United States., Honda S; Kaiser Permanente Honolulu, HI United States., Ziebell RA; Kaiser Permanente Washington Health Research Institute Seattle, WA United States., Li CI; Fred Hutchinson Cancer Center Seattle, WA United States., Zheng Y; Fred Hutchinson Cancer Center Seattle, WA United States., Hughes AE; The University of Texas Southwestern Medical Center Dallas, TX United States., Ritzwoller DP; Kaiser Permanente Aurora, CO United States., Corley DA; Kaiser Permanente Oakland, CA United States.
Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2026 Jun 03. Date of Electronic Publication: 2026 Jun 03.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42233964
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: an Evaluation of the COVID-19 Pandemic.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Del+Vecchio+NJ%22">Del Vecchio NJ</searchLink>; Fred Hutchinson Cancer Center Seattlie, Washington United States.<br /><searchLink fieldCode="AU" term="%22Doria-Rose+VP%22">Doria-Rose VP</searchLink>; National Cancer Institute Bethesda, MD United States.<br /><searchLink fieldCode="AU" term="%22Todd+KW%22">Todd KW</searchLink>; Fred Hutchinson Cancer Center Seattle, WA United States.<br /><searchLink fieldCode="AU" term="%22Rendle+KA%22">Rendle KA</searchLink>; University of Pennsylvania Philadelphia United States.<br /><searchLink fieldCode="AU" term="%22Chubak+J%22">Chubak J</searchLink>; Kaiser Permanente Washington Health Research Institute Seattle, WA United States.<br /><searchLink fieldCode="AU" term="%22Halm+EA%22">Halm EA</searchLink>; Rutgers Health New Brunswick, New Jersey United States.<br /><searchLink fieldCode="AU" term="%22Alonge+OD%22">Alonge OD</searchLink>; Marshfield Clinic Marshfield, Wisconsin United States.<br /><searchLink fieldCode="AU" term="%22Issaka+RB%22">Issaka RB</searchLink>; Fred Hutchinson Cancer Center Seattle, WA United States.<br /><searchLink fieldCode="AU" term="%22Neslund-Dudas+C%22">Neslund-Dudas C</searchLink>; Henry Ford Health System Detroit, Michigan United States.<br /><searchLink fieldCode="AU" term="%22Honda+S%22">Honda S</searchLink>; Kaiser Permanente Honolulu, HI United States.<br /><searchLink fieldCode="AU" term="%22Ziebell+RA%22">Ziebell RA</searchLink>; Kaiser Permanente Washington Health Research Institute Seattle, WA United States.<br /><searchLink fieldCode="AU" term="%22Li+CI%22">Li CI</searchLink>; Fred Hutchinson Cancer Center Seattle, WA United States.<br /><searchLink fieldCode="AU" term="%22Zheng+Y%22">Zheng Y</searchLink>; Fred Hutchinson Cancer Center Seattle, WA United States.<br /><searchLink fieldCode="AU" term="%22Hughes+AE%22">Hughes AE</searchLink>; The University of Texas Southwestern Medical Center Dallas, TX United States.<br /><searchLink fieldCode="AU" term="%22Ritzwoller+DP%22">Ritzwoller DP</searchLink>; Kaiser Permanente Aurora, CO United States.<br /><searchLink fieldCode="AU" term="%22Corley+DA%22">Corley DA</searchLink>; Kaiser Permanente Oakland, CA United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229200608%22">Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</searchLink> [Cancer Epidemiol Biomarkers Prev] 2026 Jun 03. <i>Date of Electronic Publication: </i>2026 Jun 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9200608 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210559965%22">10559965 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Epidemiol Biomarkers Prev <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42233964
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1055-9965.EPI-26-0292
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: an Evaluation of the COVID-19 Pandemic.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Del Vecchio NJ
      – PersonEntity:
          Name:
            NameFull: Doria-Rose VP
      – PersonEntity:
          Name:
            NameFull: Todd KW
      – PersonEntity:
          Name:
            NameFull: Rendle KA
      – PersonEntity:
          Name:
            NameFull: Chubak J
      – PersonEntity:
          Name:
            NameFull: Halm EA
      – PersonEntity:
          Name:
            NameFull: Alonge OD
      – PersonEntity:
          Name:
            NameFull: Issaka RB
      – PersonEntity:
          Name:
            NameFull: Neslund-Dudas C
      – PersonEntity:
          Name:
            NameFull: Honda S
      – PersonEntity:
          Name:
            NameFull: Ziebell RA
      – PersonEntity:
          Name:
            NameFull: Li CI
      – PersonEntity:
          Name:
            NameFull: Zheng Y
      – PersonEntity:
          Name:
            NameFull: Hughes AE
      – PersonEntity:
          Name:
            NameFull: Ritzwoller DP
      – PersonEntity:
          Name:
            NameFull: Corley DA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 06
              Text: 2026 Jun 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1538-7755
          Titles:
            – TitleFull: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
              Type: main
ResultId 1